Key Takeaways
- Revenue up 17% YoY, but lumpy QoQ: EMS new-customer ramp-ups drove the headline growth, while a sequential dip came from the inherently uneven build-to-spec vertical.
- Margins are the real story: Consolidated EBITDA improved from 5% to 7% YoY, and management laid out a path to 10-11% this year, with a medium-term objective of 13-15%.
- Subsidiaries are a drag turning into a tailwind: Loss-making Canadian fixed-price contracts are winding down, and the French unit is being steered toward a 10%+ EBITDA margin, with both expected to contribute positively in H2.
- The order book is flat but the pipeline is strong: Order inflow merely matched revenue this quarter, yet management expects a significant pickup, citing specific opportunities in defence, space, railways, and electric mobility.
- What to watch next quarter: Whether the promised H2 margin lift materializes as Canadian contracts complete and the onshore-offshore shift gains traction, and if order inflow accelerates to support the 20% FY24 growth target.
Margin Walk & Targets
- Q1 margin bridge: EBITDA margin rose to 7% from 5% a year ago, driven entirely by revenue improvement in the higher-margin EMS structure.
- The subsidiary penalty: Consolidated margin is being held down by the French and Canadian subsidiaries. The French unit is currently below the 10% average for its peer set, while Canadian fixed-price contracts are loss-making.
- French margin path: Management believes it can lift the French subsidiary to a 10-11% EBITDA margin even without scale, purely through better execution cost control. Beyond that, scale and shifting work onshore-to-offshore will drive further improvement.
- Canadian exit drag: Several loss-making fixed-price contracts in Canada are expected to be completed within this financial year, and the transition of operations to India should finish by year-end, removing a structural margin headwind.
- Standalone vs consolidated: Standalone EBITDA is expected to return to 12-13%, while consolidated EBITDA is guided to 10-11% for FY24, with a medium-term objective of 13-15% over two to three years, depending on business mix.
- BTEP margin shift: The BTEP segment is moving from its historical 8-9% EBITDA margin toward 10-11% or more, driven by a deliberate pivot from high-mix, low-volume defence work toward medium-volume, medium-mix industrial electronics, plus automation and digitalization under Industry 4.0.
Nikhil Mallavarapu: "even without scale we feel we should be able to improve the margin up to a 10%, 11% range. And beyond that, there will be a contribution both from scale as well as the onshore, offshore."
Subsidiary Turnaround
- First-half seasonality: Subsidiary performance is always muted in H1; the first-half EBITDA margin stood at 5%, and management expects a meaningful improvement only in the second half.
- Canada headcount rationalized: The Canadian team has been reduced to around 38 people from a higher level a year ago, achieved through natural attrition with no severance cost.
- France: margin before growth: The French subsidiary has been hit by the divestiture of its energy products division and a post-COVID industry slowdown. The first priority is to improve margins by optimizing execution costs; reasonable revenue growth is expected this year, but aggressive growth comes only after margins are fixed.
- PIS margin structure: Gross margins on PIS product deliveries are approximately 50%, but high-cost resources in Canada have been pulling down the overall realized margin.
K S Desikan: "we are bidding upon bigger projects, and thereby it will move from 10% to a higher EBITDA margin. It may not be exactly like the Indian, but it will definitely be in that direction."
Segment Growth Drivers
- EMS leads the charge: The 17% YoY revenue growth was largely driven by the EMS business unit as new customers ramped up. Management plans more aggressive expansion into automotive (a segment Centum historically did not serve) and industrials/clean tech.
- BTEP targeting >25% growth: To achieve the overall 20% consolidated growth target, the BTEP segment needs to grow at more than 25%. Confidence rests on specific opportunities where Centum is already L1 with limited competition, including development orders and some production orders for indigenized armoured-vehicle systems.
- Railways and PIS: Strong investment in railways across India and other regions is expected to drive PIS business growth. Centum won its first PIS order in India (~₹1 crore) and a Delhi Metro contract in the \$5-10 million range, executable over three to four years.
- Electric mobility: A ₹3.5 crore order from an electric mobility company, spread over four to five years, adds to the pipeline, with good order intake expected from both existing and new customers.
- China Plus One opportunity: Management has seen large US companies looking to move out of China and identify Centum as a potential candidate, presenting what it calls substantial opportunities.
- Space and defence indigenization: Centum contributed critical modules to ISRO's Chandrayaan-3 mission, received a DPSU certificate for indigenizing armoured-vehicle systems, and has formed partnerships on electronic warfare and space radar (including with Indra) to position as a direct systems supplier to the armed forces.
Order Book & Pipeline
- Flat order book this quarter: Order inflow in Q1 was roughly equivalent to revenue, leaving the order book unchanged. Management expects inflow to increase significantly in the coming quarters.
- Medium-term order book target: The objective is approximately 20% overall order book growth on a medium-term basis.
- Pipeline confidence: The outlook for the full-year order book is described as strong, supported by the opportunity pipeline across defence, space, railways, and electric mobility.
- Offset business steady: Offset business, which is part of EMS, is expected to remain relatively flat at 15-20% of overall sales.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | 20% consolidated revenue growth | FY24 |
| Consolidated EBITDA margin | 10% to 11% | FY24 |
| Standalone EBITDA margin | 12% to 13% | FY24 |
| Subsidiary business EBITDA margin | 7% to 8% (including Canada) | FY24 |
| Canadian contract completion | Loss-making fixed-price contracts completed; operations transitioned to India | By end of FY24 |
| French subsidiary EBITDA margin | At least 10% | No date; "coming quarters" |
| Medium-term consolidated EBITDA margin | 13% to 15% | Two to three years |
| Medium-term revenue CAGR | 20% | Two to three years |
| BTEP segment growth | More than 25% | FY24 (to achieve overall 20% growth) |
Key Metrics
| Metric | Q1 FY24 |
|---|---|
| Consolidated operational income | ₹244 cr, +17% YoY |
| EBITDA | ₹18 cr, +57% YoY |
| EBITDA margin | 7.33%, up from 5% in Q1 FY23 |
| Net profit | ₹1.4 cr |
| Order book | ₹1,542 cr, flat vs March level of ₹1,540 cr |
| Order book execution horizon | 12–15 months on average |
| Working capital | ~80 days, similar to March 23 levels |
| EMS revenue contribution | 39% of total |
| Standalone effective tax rate | 25% |
| Inventory days | ~105 days, same level as March 23 |
| Receivables days | ~110 days, same level as March 23 |
| Subsidiary EBITDA margin | 5% to 7%, target to improve to 7–8% for full year FY24 |
| Standalone EBITDA margin guidance | 12% to 13% for full year FY24 |
| Consolidated EBITDA margin guidance | 10% to 11% for full year FY24, medium-term objective 13% to 15% |
| Medium-term revenue growth objective | ~20% CAGR on a two-to-three-year basis |